Using inhibitor, PGE2 in CCNB2 medium was verified to enhance proliferation potential of glioma in vitro and in vivo, which worked through CCNB2/SASP/PGE2 axis in glioma cells. This evidence concerns the gene CCNB2 and central nervous system cancer.